Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Urologic Neoplasms
01. January 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 8746
Articles 1 - 20 / 174918
AI-driven precision in prostate brachytherapy: A systematic review of 70 studies.
J Cancer Res Ther
Pareek V, Dube S, Patil N, Johnny C, Mutua F, Bashir B.
PMID: 41474559 [PubMed - indexed for MEDLINE]
Development and validation of a deep learning-based model for predicting prostate cancer in patients with gray-zone PSA levels: a comparative study with clinician observations.
World J Urol
Wang Y, Zhao W, Wang R, Qi M, Zhang L, Xi D, Wang M, Yan R, Lei J.
PMID: 41474500 [PubMed - indexed for MEDLINE]
Nightshift work and risk of breast and prostate cancer: a systematic review and meta-analysis, 2012-2023.
An Sist Sanit Navar
Soler-Saña M, Puiggené-Vallverdú M, Godoy P.
PMID: 41473964 [PubMed - indexed for MEDLINE]
A Single-Center, Retrospective, Real-World, Observational Clinical Study to Evaluate the Safety and Efficacy of Abiraterone (Abiratred) in Patients with Metastatic Prostate Cancer.
South Asian J Cancer
Danchaivijitr P, Archwamety A, Wongkraisri C.
PMID: 41473368 [PubMed]
(18)F-florastamin positron emission tomography/computed tomography in men with clinical suspicion of prostate cancer: A phase I prospective study.
Prostate Int
Park SY, Moon HW, Park C, Chi DY, Yoo IR, Lee JY.
PMID: 41472932 [PubMed]
Utility of the prostate health index density for detecting clinically significant prostate cancer in patients with negative magnetic resonance imaging findings.
Prostate Int
Oshinomi K, Kikuchi S, Kishi H, Hayashi A, Okada S, Kurokawa M, Mugita T, Tsunokawa Y, Inoue T, Yamagishi M, Nakagami Y, Nagata M, Fukagai T.
PMID: 41472930 [PubMed]
Clinical implication of peri-seminal vesicle soft-tissue invasion in patients with pT3b prostate cancer.
Prostate Int
Bang S, Shin SJ, Kim DK, Kwon JK, Jeon J, Cho KS.
PMID: 41472925 [PubMed]
Comparison of 7-tesla ex vivo and conventional 3-tesla magnetic resonance imaging for prostate cancer staging.
Prostate Int
Kim TM, Song SH, Hwang SI, Hong SK, Byun SS, Choe G, Jee HM, Park SW, Ahn H.
PMID: 41472924 [PubMed]
Temporal trends of prostate cancer diagnostics in Australia: Has the introduction of a magnetic resonance imaging prostate subsidy fulfilled its cost-saving promises?
Prostate Int
Qiu M, Rahman A, Kuo LY, Ponen K, Chen M.
PMID: 41472920 [PubMed]
Leiomyosarcoma of the right renal vein with tumour thrombus extending to the right atrium - Case Report and literature review.
Ann Agric Environ Med
Godzisz M, Yadlos A, Szklener K, Kuliniec I, Sudo, Mitura P, Bar K.
PMID: 41472596 [PubMed - indexed for MEDLINE]
DAXX and ATRX Expression in Canine Prostate and Bladder Cancer Identified by Immunohistochemistry-A Digital Quantitative Pilot Study.
Vet Sci
Spitzer A, Aupperle-Lellbach H, Spitzer M, Weidle S, Aeschlimann L, Schwinn J, Klopfleisch R, de Brot S.
PMID: 41472189 [PubMed]
The Olive Phenolic S-(-)-Oleocanthal as a Novel Intervention for Neuroendocrine Prostate Cancers: Therapeutic and Molecular Insights.
Nutrients
Tarun MTI, Ebrahim HY, Dawud D, Elmageed ZYA, Corey E, El Sayed KA.
PMID: 41470892 [PubMed - indexed for MEDLINE]
Urinary Microbiota Composition in Treatment-Naïve Bladder Cancer: A Case-Control Study with Tumor Invasiveness Stratification.
Medicina (Kaunas)
Kayer A, Özen A, Dinleyici EÇ.
PMID: 41470243 [PubMed - indexed for MEDLINE]
Comparative Analysis of Transperineal Cognitive Fusion, Systematic, and Combined Biopsies for Prostate Cancer Detection.
Medicina (Kaunas)
Radu MA, Mirea SC, Droca, Florin DV, Dr, Mitroi G, P, Dr.
PMID: 41470187 [PubMed - indexed for MEDLINE]
Proteoglycans in Prostate Cancer Progression and Therapy Resistance.
Medicina (Kaunas)
Samar.
PMID: 41470114 [PubMed - indexed for MEDLINE]
Prognostic Significance of Ultralow (UL) Prostate-Specific Antigen (PSA) in Patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): A Single Institution and Tertiary Cancer Center Experience.
Medicina (Kaunas)
Suton P, Gregov V.
PMID: 41470112 [PubMed - indexed for MEDLINE]
Diagnostic accuracy of prostate-specific antigen and prostate-specific antigen density in patients suspected of having prostate cancer in South Korea: A large, multi-institutional registry.
Investig Clin Urol
Yun JE, Lee KS, Lee H, Lee SH, Jung JH, Hwang EC, Lee NR, Han WK, Yu SY.
PMID: 41469904 [PubMed - indexed for MEDLINE]
Preoperative serum albumin level is associated with postoperative short- and long-term renal function deterioration in patients who underwent radical cystectomy for bladder cancer.
Investig Clin Urol
Song B, Lee H, Lee S, Hong SK, Byun SS, Oh JJ.
PMID: 41469903 [PubMed - indexed for MEDLINE]
Artificial intelligence-based personalized oncological outcome prediction model for upper urinary tract urothelial carcinoma after radical nephroureterectomy: A development and multicenter validation.
Investig Clin Urol
Lee HY, Kim H, Lim B, You D, Song C, Jeong IG, Hong JH, Hong B, Ahn H, Jeong SH, Ku JH, Suh J.
PMID: 41469902 [PubMed - indexed for MEDLINE]
Trop2 immuno-PET/CT imaging of prostate cancer: a proof-of-concept translational study.
BMC Med
Long X, An S, Nian X, Xu D, Wei W, Lan X, Dong L, Jiang D.
PMID: 41469668 [PubMed - as supplied by publisher]
Articles 1 - 20 / 174918
Page 1 of 8746
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy